Tokio Marine Asset Management Co. Ltd. Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Tokio Marine Asset Management Co. Ltd. grew its holdings in Teleflex Incorporated (NYSE:TFX) by 48.3% during the 4th quarter, Holdings Channel reports. The fund owned 2,250 shares of the medical technology company’s stock after purchasing an additional 733 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Teleflex were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the business. Janus Henderson Group PLC boosted its holdings in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after acquiring an additional 147,147 shares during the last quarter. State Street Corp boosted its holdings in shares of Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after acquiring an additional 21,291 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after acquiring an additional 5,746 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its holdings in Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after buying an additional 96,958 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Truist Financial lowered their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Mizuho lowered their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Teleflex currently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Stock Performance

NYSE:TFX opened at $175.04 on Wednesday. The company has a fifty day moving average of $181.48 and a two-hundred day moving average of $212.46. The stock has a market capitalization of $8.13 billion, a PE ratio of 34.80, a P/E/G ratio of 1.78 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a fifty-two week low of $171.69 and a fifty-two week high of $256.85.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.